David Van Echo
Impact in
- Otorhinolaryngology top 5%
- Head and Neck Cancer Studies
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Oncology 14
- Cancer Treatment and Pharmacology 6
- Cancer-related Molecular Pathways 2
- Colorectal Cancer Treatments and Studies 2
- Lung Cancer Research Studies 2
-
- Lung Cancer Treatments and Mutations 3
- Co-authors
- EA Mittendorf (1 shared paper)Sathibalan Ponniah (1 shared paper)Guy T. Clifton (1 shared paper)George E. Peoples (1 shared paper)Erika J Schneble (1 shared paper)Jarrod P. Holmes (1 shared paper)Mario A. Eisenberger (4 shared papers)Javier Hornedo (1 shared paper)
- Journals
- Journal of Clinical Oncology (6 papers)Cancer Chemotherapy and Pharmacology (2 papers)Molecular Therapy (1 paper)Medical Decision Making (1 paper)The Journal of Experimental Medicine (1 paper)
- Partner nations
- United StatesNew ZealandJapan
In The Last Decade
David Van Echo
25 papers receiving 906 citations
Peers
Comparison fields: 5 of 100
- Otorhinolaryngology 110
- Oncology 327
- Immunology 256
- Hepatology 37
- Public Health, Environmental and Occupational Health 106
Countries citing papers authored by David Van Echo
This map shows the geographic impact of David Van Echo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Van Echo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Van Echo more than expected).
Fields of papers citing papers by David Van Echo
This network shows the impact of papers produced by David Van Echo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Van Echo. The network helps show where David Van Echo may publish in the future.
Co-authors
The 25 scholars most cited alongside David Van Echo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 201 | |
| 2 | 2003 | 177 | |
| 3 | 2007 | 137 | |
| 4 | 1986 | 106 | |
| 5 | 2003 | 76 | |
| 6 | 2004 | 46 | |
| 7 | 1989 | 36 | |
| 8 | 2011 | 27 | |
| 9 | 1997 | 25 | |
| 10 | 2004 | 21 | |
| 11 | 1986 | 14 | |
| 12 | 2008 | 13 | |
| 13 | 1982 | 12 | |
| 14 | 2018 | 10 | |
| 15 | Phase II evaluation of bisantrene in patients with renal cell carcinoma. | 1982 | 10 |
| 16 | Phase II study of caracemide in advanced or recurrent non-small cell lung cancer. | 1987 | 8 |
| 17 | 2001 | 7 | |
| 18 | Phase II study of N-methylformamide in patients with advanced colorectal cancer. | 1987 | 4 |
| 19 | Phase II trial of aziridinylbenzoquinone (AZQ) in head and neck cancer. | 1982 | 4 |
| 20 | 2007 | 3 |
About David Van Echo
David Van Echo is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Otorhinolaryngology and Epidemiology, having authored 26 papers that have together received 947 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (6 papers), Head and Neck Cancer Studies (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Lung Cancer Treatments and Mutations (3 papers), Cancer-related Molecular Pathways (2 papers), Colorectal Cancer Treatments and Studies (2 papers), Lung Cancer Research Studies (2 papers) and Neuroendocrine Tumor Research Advances (2 papers). The work is most often cited by research in Otorhinolaryngology (110 citations), Oncology (327 citations), Immunology (256 citations), Hepatology (37 citations) and Public Health, Environmental and Occupational Health (106 citations). David Van Echo has collaborated with scholars based in United States, New Zealand and Japan. Frequent co-authors include EA Mittendorf, Sathibalan Ponniah, Guy T. Clifton, George E. Peoples, Erika J Schneble, Jarrod P. Holmes, Mario A. Eisenberger, Javier Hornedo, Monica B. Spaulding and Ross C. Donehower. Their work appears in journals such as Journal of Clinical Oncology, Cancer Chemotherapy and Pharmacology, Molecular Therapy, Medical Decision Making and The Journal of Experimental Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.